Children's Behavioral Medication Costs Soar

Published Online: Monday, November 1, 2004

Medco Health Solutions 2004 Drug Trend Report has revealed eye-opening data about medication spending to treat behavioral disorders in pediatric patients. Specifically, spending on drugs primarily used to treat attention-deficit/hyperactivity disorder skyrocketed by 369% for children under age 5. The number of children taking 1 or more prescription medications to treat behavior-related conditions hit almost 9% for those children taking at least 1 medication overall. Other significant findings of the analysis are as follows:

  • Prescription drug spending for behavioral conditions rose by 77% between 2000 and 2003 as a result of increased costs and the increased use of these medications
  • In 2003, spending on behavioral medications to treat children overtook both the antibiotic and asthma categories, which are traditionally high-use categories in pediatric medicine
  • The number of children taking behavioral medications jumped by >20% between 2000 and 2003, outpaced only by the increase in children on drugs to treat gastrointestinal conditions, which increased by 28%


Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues
$auto_registration$
VSEO N/A